Lanean...
Early Use of Dinutuximab Beta in Patients with High-Risk Neuroblastoma
Neuroblastoma is the most common extracranial solid tumor in children, accounting for 15% of all pediatric cancer deaths. High-risk neuroblastoma (HRNB) is a particularly difficult-to-treat form of the disease that requires aggressive multimodality therapy, including induction chemotherapy, consolid...
Gorde:
| Argitaratua izan da: | Case Rep Pediatr |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hindawi
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8235958/ https://ncbi.nlm.nih.gov/pubmed/34239748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6610955 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|